ReviewPharmacology & therapeutics2015

Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Rainer Schulz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.